You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic myelogenous leukemia (CML)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Completed
  • Chronic Myeloid Leukemia
  • 3L Therapy
  • T315I
  • Lyon, France
    Novartis Investigative Site
Nov 9, 2022

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

Recruiting
  • Leukemia, Chronic Myelogenous
  • Chongqing City, Chongqing, China
  • +23 more
Jan 18, 2023

CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

Not yet recruiting
  • CML, Chronic Phase
  • Harbin, Heilongjiang, China
    Institute of Hematology and Oncology, Harbin The First Hospital
May 5, 2022

Chronic Myeloid Leukemia Trial in New York (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Mar 24, 2022

Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

Recruiting
  • Chronic Myeloid Leukemia in Chronic Phase
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Jul 26, 2022

Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

Recruiting
  • Olverembatinib
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Jul 26, 2022

Study Conducted Among Patients With CML

Completed
  • Chronic Myeloid Leukemia
  • Tyrosine Kinase Inhibitors (TKIs)
  • East Hanover, New Jersey
    Novartis Investigative Site
Jul 25, 2022

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)

Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 21, 2021

Flumatinib, Chronic Myeloid Leukemia, Chronic Phase, Imatinib Trial in Shenzhen (Flumatinib)

Recruiting
  • Flumatinib
  • +2 more
  • Shenzhen, Guangdong, China
    The Second People's Hospital of Shenzhen
Mar 15, 2022

TKI Discontinuation in CML Patients of China

Recruiting
  • Leukemia
  • +4 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Mar 15, 2022

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    CML (Chronic Myelogenous Leukemia) Trial in Guanzhou (questionnaire)

    Recruiting
    • CML (Chronic Myelogenous Leukemia)
    • questionnaire
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Oct 11, 2021

    CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

    Recruiting
    • CML, Chronic Phase
    • Flumatinib mesylate tablets (400mg)
    • Flumatinib mesylate tablets (600mg)
    • Harbin, Hei Longjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    Apr 28, 2022

    Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

    Completed
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Angers, France
    • +9 more
    Aug 17, 2022

    CML Patients in the National Compassionate Program

    Terminated
    • Chronic Myeloid Leukemia
    • Philadelphia Positive
    • Bari, Italy
    • +9 more
    Oct 24, 2022

    Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

    Terminated
    • Accelerated Phase Chronic Myelogenous Leukemia (CML)
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2020

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022